Sort
51,570 grants matching “autoimmune disease”
Megakaryocyte Transcription Factor Activation to Enhance In Vitro Platelet Production from Human IPSCs
$510,370Alan B. Cantor · Boston Children'S Hospital · R01 · FY2017 · HL
Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes.
$510,294Lawrence L. Fisher · University Of California, San Francisco · R01 · FY2017 · DK
Defining the effector gene repertoire in systemic autoimmunity by ENU mutagenesis
$510,288Dwight H Kono · Scripps Research Institute, The · R01 · FY2011 · AR
Investigation and Development of New Therapeutic Avenues for Scleroderma
$510,250Emanual M. Maverakis · University Of California At Davis · DP2 · FY2016 · OD
Vasculitis and Translational Medicine
$510,240Peter Grayson · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation
$510,221Drew James Adams · Case Western Reserve University · R01 · FY2023 · AI
Commensal microbiota modulates ocular surface mucosal inflammation
$510,210Cintia Sade De Paiva · Baylor College Of Medicine · R01 · FY2017 · EY
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2022 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2023 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2020 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2019 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2021 · AI
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
$510,193Yuri Sykulev · Thomas Jefferson University · U01 · FY2021 · AI
Psychosocial Factors and Lupus Disease Progression Among African American Women
$510,185H. David Chae · Auburn University At Auburn · R01 · FY2016 · AR
MODULATING AUTOIMMUNE DISEASE BY FC RECEPTORS
$510,100Rockefeller University · R01 · FY2004 · AI
Modulating the senescence secretome to block progression of T1D
$510,033Anil Bhushan · University Of California, San Francisco · R01 · FY2021 · DK
Modulating the senescence secretome to block progression of T1D
$510,033Anil Bhushan · University Of California, San Francisco · R01 · FY2022 · DK
Modulating the senescence secretome to block progression of T1D
$510,033Anil Bhushan · University Of California, San Francisco · R01 · FY2023 · DK
Immunoengineering Postdoctoral Training Program - Resubmission - 1
$510,014Melody A Swartz · University Of Chicago · T32 · FY2025 · AI
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2019 · HL
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2022 · HL
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2020 · HL
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2021 · HL
Blood-Brain Barrier Deficit and Brain Injury in Obstructive Sleep Apnea
$509,983Rajesh Kumar · University Of California Los Angeles · R01 · FY2017 · NR
Blood-Brain Barrier Deficit and Brain Injury in Obstructive Sleep Apnea
$509,978Rajesh Kumar · University Of California Los Angeles · R01 · FY2015 · NR